Almirall Extends Dermatology Reach With Dermira Lebrikizumab Deal

 Atopic dermatitis
Lebrikizumab is being tested in moderate-to-severe atopic dermatitis • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Deals

More from Business